| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/26/2001 | WO2001028342A1 Oligodendrocyte cell cultures and methods for their preparation and use |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2001003645A3 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000074703A3 Therapeutic agent comprising a botulinum neurotoxin |
| 04/26/2001 | WO2000071723A3 Methods for regulating protein conformation using molecular chaperones |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000063246A3 Compounds and methods for modulating beta-catenin mediated gene expression |
| 04/26/2001 | WO2000061609B1 Prodrugs of thrombin inhibitors |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | WO2000048445A3 Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence |
| 04/26/2001 | WO2000008020A8 Tricyclic carboxamides |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | DE19950898A1 New heteroaryl substituted fluoroalkyl-benzoylguanidine derivatives useful for treatment of e.g. ischemias, cardiac infarction, angina, shock, atherosclerosis, cancer and metabolic disorders |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | DE19950066A1 Transdermal therapeutic system based on polyacrylate matrix carrier comprises tulobuterol hydrochloride |
| 04/26/2001 | DE19938825A1 Wirkstoffkombination mit Clonidin Drug combination with clonidine |
| 04/26/2001 | DE19932621A1 Neue substituerte alpha, beta-anellierte Butyrolactone New substituerte alpha, beta-fused butyrolactones |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388503A1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2388357A1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 04/26/2001 | CA2387974A1 N-substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones for use as promoter of .gamma.-aminobutyric acid activity and for treating nervous disorders andpreparation method |
| 04/26/2001 | CA2387972A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 04/26/2001 | CA2387892A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | CA2387846A1 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | CA2387819A1 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | CA2387810A1 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | CA2387748A1 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
| 04/26/2001 | CA2387138A1 Cannabimimetic indole derivatives |
| 04/26/2001 | CA2387031A1 Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386149A1 Allosteric sites on muscarinic receptors |
| 04/26/2001 | CA2385472A1 Isoxazolecarboxamide derivatives |
| 04/26/2001 | CA2384789A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 04/26/2001 | CA2384573A1 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 04/26/2001 | CA2384264A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | CA2382978A1 Powder pharmaceutical formulations |
| 04/25/2001 | WO2000012044A2 Method for the preparation of citalopram |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094064A1 5-arylindolederivatives and their use as serotonin(5-ht1)agonists |
| 04/25/2001 | EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators |
| 04/25/2001 | EP1093815A1 Oral 2-methyl-thieno-benzodiazepine formulation |
| 04/25/2001 | EP1093814A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 04/25/2001 | EP1093810A1 Fast-dissolving tablet comprising brotizolam |
| 04/25/2001 | EP1093580A1 Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093453A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 04/25/2001 | EP1093379A2 Use of inhibitors of protein kinase c epsilon to treat pain |
| 04/25/2001 | EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 04/25/2001 | EP1093369A2 Agents with an antidepressive effect |
| 04/25/2001 | EP1093366A1 Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles |
| 04/25/2001 | EP1093365A2 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 04/25/2001 | EP1093348A1 Methods and transdermal compositions for pain relief |
| 04/25/2001 | EP0994872B1 4-phenylpiperidine compounds |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292789A 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 04/25/2001 | CN1292701A Glucocorticoid receptor antagonists for treatment of dementia |
| 04/25/2001 | CN1292698A Glycine transport inhibitors |
| 04/25/2001 | CN1292696A Composition |
| 04/25/2001 | CN1292693A Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 04/25/2001 | CN1292638A Gene mutant animals |
| 04/25/2001 | CN1292294A Preparation of brain-tonifying blood circulation promoting extract powder and its preparation process |
| 04/25/2001 | CN1292273A Five-medicine tranquilization preparation |
| 04/25/2001 | CN1064966C Condesned thiazole derivatives, having 5-HT receptor affinity |
| 04/25/2001 | CN1064964C Novel benzobiukyl, preparation of same and parmaceutical composition of same |
| 04/25/2001 | CN1064959C N-substituted azabicycloheptane derivatives and preparing process and use thereof |
| 04/25/2001 | CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 04/25/2001 | CN1064840C New use of Chinese medicine Morinda officinalis extractive for curing mental disease |
| 04/25/2001 | CA2324116A1 Nk-1 receptor antagonists and eletriptan for the treatment of migraine |
| 04/24/2001 | US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222034 As serotinin receptor antagonists; for therapy of depression, central nervous system disorders |
| 04/24/2001 | US6222027 Molecules expressed in hippocampus |
| 04/24/2001 | US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies |
| 04/24/2001 | US6221915 Pharmaceutical compositions |
| 04/24/2001 | US6221904 Administering to the subject an amount of dehydroascorbic acid |
| 04/24/2001 | US6221891 Crystal form of N-(4-triflouromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221879 8-azabicyclo[3.2.1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors |
| 04/24/2001 | US6221870 Treatment of depression, anxiety, bipolar disorders and adhd |
| 04/24/2001 | US6221867 4,5-pyrazinoxindoles |
| 04/24/2001 | US6221858 Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders |
| 04/24/2001 | US6221670 Methods to identify β-amyloid reducing agents |
| 04/24/2001 | US6221667 Packaged pharmaceutical composition includes a mobile ionophore which prevents or decreases amyloid precursor protein catabolism in cells without altering cell viability in a pharmaceutical vehicle in a container, and instructions |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | US6221377 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 04/24/2001 | US6221376 Glial cell line-derived neurotrophic factor |
| 04/24/2001 | CA2222976C Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 04/24/2001 | CA2188703C Therapeutic injectable analgesic pharmaceutical composition containing nimesulide 4-nitro, 2-phenoxyphenyl methane sulphonamide for intramuscular administration |
| 04/24/2001 | CA2166203C Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]- 6-chloro-1,3-dihydro-indol-2-one |
| 04/24/2001 | CA2101164C Orally administerable drugs for the treatment of central dopamine deficiency conditions |